Literature DB >> 12354833

Epidemiology and clinical presentation of hepatocellular carcinoma.

Adrian M Di Bisceglie1.   

Abstract

Hepatocellular carcinoma (HCC) is one of the most common internal malignancies worldwide. Until recently, it has occurred relatively rarely in the West. Now, however, it appears to be rising in incidence in the United States and other developed western countries. The most frequent underlying factors causing HCC are chronic viral hepatitis and cirrhosis. Common clinical features include abdominal pain and worsening of hepatic synthetic function. More recently, however, patients with asymptomatic tumors are being diagnosed because of more frequent screening and improvements in imaging techniques. Early detection of HCC is a key factor in improving outcomes of therapies. There is growing evidence that HCC may be prevented with strategies aimed at preventing or treating viral hepatitis.

Entities:  

Mesh:

Year:  2002        PMID: 12354833     DOI: 10.1016/s1051-0443(07)61783-7

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  27 in total

1.  Protein kinase D negatively regulates hepatitis C virus secretion through phosphorylation of oxysterol-binding protein and ceramide transfer protein.

Authors:  Yutaka Amako; Gulam H Syed; Aleem Siddiqui
Journal:  J Biol Chem       Date:  2011-02-01       Impact factor: 5.157

Review 2.  Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis.

Authors:  Asmaa-Ibrahim Gomaa; Shahid-A Khan; Mireille-B Toledano; Imam Waked; Simon-D Taylor-Robinson
Journal:  World J Gastroenterol       Date:  2008-07-21       Impact factor: 5.742

3.  Nanocomposite Carriers for Transarterial Chemoembolization of Liver Cancer.

Authors:  Dong-Hyun Kim; Andrew C Larson
Journal:  Interv Oncol 360       Date:  2016-11-17

4.  Irreversible electroporation of the liver and liver hilum in swine.

Authors:  Kevin P Charpentier; Farrah Wolf; Lelia Noble; Brody Winn; Murray Resnick; Damian E Dupuy
Journal:  HPB (Oxford)       Date:  2011-01-25       Impact factor: 3.647

5.  Silence of p15 expression by RNAi enhances cisplatin resistance in hepatocellular carcinoma cells.

Authors:  Dianliang Fang; Yuanhong Guo; Zhenshuang Zhu; Weiqing Chen
Journal:  Bosn J Basic Med Sci       Date:  2012-02       Impact factor: 3.363

Review 6.  Cyclooxygenases in hepatocellular carcinoma.

Authors:  Melchiorre Cervello; Giuseppe Montalto
Journal:  World J Gastroenterol       Date:  2006-08-28       Impact factor: 5.742

7.  Radiofrequency ablation of hepatocellular carcinoma: Current status.

Authors:  Yasunori Minami; Masatoshi Kudo
Journal:  World J Radiol       Date:  2010-11-28

8.  Perfusion reduction at transcatheter intraarterial perfusion MR imaging: a promising intraprocedural biomarker to predict transplant-free survival during chemoembolization of hepatocellular carcinoma.

Authors:  Dingxin Wang; Ron C Gaba; Brian Jin; Robert J Lewandowski; Ahsun Riaz; Khairuddin Memon; Robert K Ryu; Kent T Sato; Laura M Kulik; Mary F Mulcahy; Andrew C Larson; Riad Salem; Reed A Omary
Journal:  Radiology       Date:  2014-03-28       Impact factor: 11.105

Review 9.  Radiofrequency ablation of cancer.

Authors:  Marc Friedman; Igor Mikityansky; Anthony Kam; Steven K Libutti; McClellan M Walther; Ziv Neeman; Julia K Locklin; Bradford J Wood
Journal:  Cardiovasc Intervent Radiol       Date:  2004-06-03       Impact factor: 2.740

10.  Liver angiogenesis as a risk factor for hepatocellular carcinoma development in hepatitis C virus cirrhotic patients.

Authors:  Roberto Mazzanti; Luca Messerini; Camilla E Comin; Lorenzo Fedeli; Nathalie Ganne-Carrie; Michel Beaugrand
Journal:  World J Gastroenterol       Date:  2007-10-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.